Source: Eur Respir J, 53 (3) 1801523; 10.1183/13993003.01523-2018



Rating:

Share or cite this content

Citations should be made in the following way:
Donna M. Small, Ryan R. Brown, Declan F. Doherty, Anthony Abladey, Zhe Zhou-Suckow, Rebecca J. Delaney, Lauren Kerrigan, Caoifa M. Dougan, Keren S. Borensztajn, Leslie Holsinger, Robert Booth, Christopher J. Scott, Guillermo López-Campos, J. Stuart Elborn, Marcus A. Mall, Sinéad Weldon, Clifford C. Taggart. Targeting of cathepsin S reduces cystic fibrosis-like lung disease. Eur Respir J, 53 (3) 1801523; 10.1183/13993003.01523-2018

Member's Comments

No comment yet.

Related content which might interest you: A role for cathepsin S in the pathogenesis of cystic fibrosis lung disease? Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 Inhibition of airway proteases in cystic fibrosis lung disease Source: Eur Respir J 2008; 32: 783-795 Year: 2008 Investigating the role of cathepsin S in the pathogenesis of cystic fibrosis-like lung disease Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Potential role of cathepsin S in bleomycin-induced lung fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 729s Year: 2005 Neutrophilic inflammation predisposes to structural lung disease in cystic fibrosis (CF) via neutrophil elastase activity Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies Year: 2009 The role of cathepsin S in lung disease Source: International Congress 2018 – Proteases: at the cutting edge of lung disease Year: 2018 The role of matrix metalloproteinases in cystic fibrosis lung disease Source: Eur Respir J 2011; 38: 721-727 Year: 2011 Increased epithelial production of LPLUNC1 in cystic fibrosis lung disease Source: Annual Congress 2011 - Epithelial cell biology Year: 2011 Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis Source: Eur Respir J, 51 (3) 1701910; 10.1183/13993003.01910-2017 Year: 2018 Loss of PTEN induced lung fibroblasts exhibiting similar pathogenic features to cancer cells in idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 2 Year: 2014 Decreased levels of secretory leucoprotease inhibitor in the pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 Early cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 77-87 Year: 2014 Distribution and characterisation of lung mast cells in cystic fibrosis Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 Is cathepsin K a protective factor in the development of lung fibrosis? Source: Eur Respir J 2002; 20: Suppl. 38, 479s Year: 2002 CXCR4+ granulocytes reflect fungal cystic fibrosis lung disease Source: Eur Respir J 2015; 46: 395-404 Year: 2015 KCa3.1 channel inhibition prevents fibrotic responses in a human lung explant model Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Neutrophil elastase and lung damage in cystic fibrosis Source: International Congress 2018 – Proteases: at the cutting edge of lung disease Year: 2018 Peptide transport mechanisms in cystic fibrosis and normal human lung Source: Eur Respir J 2001; 18: Suppl. 33, 76s Year: 2001 Bromodomain inhibitor JQ1 attenuates TGF-beta-suppressed SOD2 expression and reduces proliferation in human primary pulmonary fibroblasts Source: Annual Congress 2013 –The multiple faces of stress in lung injury Year: 2013 Cathepsin S as a mediator of acute lung inflammation Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019